Sreeparna Pharmaceutical Distributors Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 04-07-2024
- Paid Up Capital ₹ 4.50 M
as on 04-07-2024
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 04-07-2024
- Satisfied Charges ₹ 1.00 Cr
as on 04-07-2024
- Revenue -23.31%
(FY 2021)
- Profit -42.36%
(FY 2021)
- Ebitda -2132.53%
(FY 2021)
- Net Worth 2.08%
(FY 2021)
- Total Assets -14.14%
(FY 2021)
About Sreeparna Pharmaceutical Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Madhu Nair and Damodar Avanoor serve as directors at the Company.
- CIN/LLPIN
U51397KL2009PTC024431
- Company No.
024431
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 2009
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Malappuram, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sreeparna Pharmaceutical Distributors?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhu Nair  | Director | 08-Jul-2009 | Current |
| Damodar Avanoor | Director | 08-Jul-2009 | Current |
Financial Performance of Sreeparna Pharmaceutical Distributors.
Sreeparna Pharmaceutical Distributors Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 23.31% decrease. The company also saw a substantial fall in profitability, with a 42.36% decrease in profit. The company's net worth moved up by a moderate rise of 2.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sreeparna Pharmaceutical Distributors?
In 2021, Sreeparna Pharmaceutical Distributors had a promoter holding of 46.00% and a public holding of 54.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Chelamala Field Latex Producer Company LimitedActive 5 years 7 months
Damodar Avanoor is a mutual person
- Chethana Remedies (India) Private LimitedActive 14 years 11 months
Damodar Avanoor is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dhanlaxmi Bank Limited Creation Date: 04 Mar 2020 | ₹1.00 Cr | Open |
The Federal Bank Limited Creation Date: 27 Feb 2010 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Sreeparna Pharmaceutical Distributors?
Unlock and access historical data on people associated with Sreeparna Pharmaceutical Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sreeparna Pharmaceutical Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sreeparna Pharmaceutical Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
